That's the title of a KFF article revealed final week. The outcomes are based mostly on the KFF's Employer Well being Advantages Survey 2024. They write:

For the KFF survey of two,142 randomly chosen corporations, officers from corporations with 500 or extra workers had been requested how most of the reductions had been negotiated by the KFF. [pharmacy benefit managers] PPE returned to the corporate as financial savings. About 19% mentioned they obtained most reductions, 27% mentioned some, and 16% mentioned few. Thirty-seven p.c of respondents didn’t know.
Though a bigger proportion of officers on the largest corporations mentioned they obtained most or a few of the reductions, the responses — and their distinction with the testimonials of PBM leaders — replicate employers' confusion or ignorance about what their directors consider drug advantages, the examine mentioned. chief Gary Claxton, senior vp at KFF, a nonprofit well being data group that features KFF Well being Information.
“I don't assume they’ll ever know all of the methods the cash strikes as a result of there are such a lot of layers between the wholesalers, the pharmacies and the producers,” he mentioned.

“Employers normally are annoyed by the dearth of transparency round all of the pricing on the market,” Claxton mentioned. “They will't really know what’s true.”

Do you assume PBMs result in larger or decrease pharmacy prices?